Symposia: Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Adult, Clinical trials, Combination therapy, Translational Research, Epidemiology, Drug development, Clinical Research, Health outcomes research, Hemoglobinopathies, Health disparities research, Pediatric, Hematopoiesis, Diseases, Patient-reported outcomes, Treatment Considerations, Non-Biological therapies, Adverse Events, Metabolism, Young adult , Biological Processes, Surgical, Technology and Procedures, Study Population, Human, Machine learning
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Adult, Clinical trials, Combination therapy, Translational Research, Epidemiology, Drug development, Clinical Research, Health outcomes research, Hemoglobinopathies, Health disparities research, Pediatric, Hematopoiesis, Diseases, Patient-reported outcomes, Treatment Considerations, Non-Biological therapies, Adverse Events, Metabolism, Young adult , Biological Processes, Surgical, Technology and Procedures, Study Population, Human, Machine learning
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Hall B
(San Diego Convention Center)
Moderators:
Shaniqua Johnson Anum, MD, ARRAY(0xf189fb0)
and
Oladipo Cole, MD, MBA, University of Connecticut
Disclosures:
Cole: Novo Nordisk: Consultancy, Honoraria; Agios: Honoraria.
This session is about sickle cell research that encompasses the globe and research that focuses on sickle cell care across the lifetime of the individuals living with Sickle Cell Disease.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH